- Home
- GH vs AIZ Comparison
GH vs AIZ Comparison
Compare GH & AIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GH | AIZ |
|---|---|---|
| Founded | 2011 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 11.9B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | GH | AIZ |
|---|---|---|
| Price | $101.85 | $243.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 6 |
| Target Price | $102.81 | ★ $251.83 |
| AVG Volume (30 Days) | ★ 2.1M | 331.5K |
| Earning Date | 02-19-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ 17.21 |
| EPS | N/A | ★ 16.41 |
| Revenue | $902,569,000.00 | ★ $12,568,700,000.00 |
| Revenue This Year | $35.23 | $8.63 |
| Revenue Next Year | $27.38 | $5.50 |
| P/E Ratio | ★ N/A | $14.78 |
| Revenue Growth | ★ 30.38 | 6.92 |
| 52 Week Low | $34.88 | $174.97 |
| 52 Week High | $120.74 | $245.02 |
Technical Indicators
Market Signals| Indicator | GH | AIZ |
|---|---|---|
| Relative Strength Index (RSI) | 38.60 | 65.41 |
| Support Level | $97.88 | $239.15 |
| Resistance Level | $118.00 | $245.02 |
| Average True Range (ATR) | 5.67 | 4.39 |
| MACD | -1.94 | 0.61 |
| Stochastic Oscillator | 11.61 | 99.78 |
Price Performance
Historical ComparisonAbout GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.